Menu
EMAHSN
Qbtech banner cropped

ADHD begins in childhood and often persists into adult life. Latest statistics from the Centre of Mental Health suggest that around 1.5% of young people aged 5-16 years have ADHD: around 12,000 young people are estimated to have the condition in the East Midlands, with a long-term cost to society of £100,000 per case, or £12m.

Public Health England estimates that the number of East Midlands’ young people with ADHD in the 16-24 age range is even higher, at more than 76,000.  Over the last 10 years there has been a six-fold increase in the prevalence and rate of medication prescriptions for ADHD in the UK.

Currently, assessment and diagnosis is based on subjective clinical observation, interviews and observer questionnaire reports.

EMAHSN is working with international company Qbtech Ltd to spread the use of an innovative computerised test for Attention Deficit Hyperactivity Disorder (ADHD).  ‘QbTest’ is the only CE marked and Food and Drug Administration (FDA) cleared, ADHD test that measures attention, impulsivity and motor activity all at the same time – a core requirement for accurate and timely diagnosis of ADHD. project is being rolled out during 2017 within 7 sites across Derbyshire, Leicestershire and Lincolnshire.

The East Midlands project aims to transform care within the region by using the computerised system - alongside observation and interviews – to improve diagnosis and deliver significant savings to trusts. This will be achieved by reducing the number of appointments to diagnosis, and by ruling out ADHD sooner for ambiguous cases.

More information: contact EMAHSN Project Manager, Guy Wood.